Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP ...

But he wouldn't commit to specific actions on a host of hot-button issues ... restrict mifepristone following legal battles over access. Like other drugs, the FDA continues to collect reports ...

The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation ...

The country’s only manufacturer of generic abortion medication asked to be a part of the first legal fight over the ... to ...

According to the FDA website, the agency issues a Class I recall in "a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious ...

Supply issues finally started to ease late in 2024, as compounded semaglutide — "copycats" of the patented stuff like Ozempic and Zepbound — began to flood the market when the FDA temporarily ...